Abstract
BackgroundDefects in retinol dehydrogenase 12 (RDH12) account for 3.4%–10.5 % of Leber congenital amaurosis and early-onset severe retinal dystrophy (EOSRD) and are a potential target for gene therapy. Clinical trials...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have